Outlet metrics

Domain Authority
89
Ranking

Global

#17042

United Kingdom

#778

Science and Education/Universities and Colleges

#13

Traffic sources
Monthly visitors

Articles

  • 3 days ago | imperial.ac.uk | Gege Li

    Thanks to a new philanthropic partnership with CD Capital, ESE will offer the new scholarship to support exceptional female students who demonstrate outstanding academic merit or potential and are starting an MSc in Metals and Energy Finance.

  • 6 days ago | imperial.ac.uk | David Silverman

    Speaking to an audience of scientists and aspiring entrepreneurs, some of Imperial’s top company founders joined a panel last month at the Imperial Founders Forum, where they talked about their journeys from academia to entrepreneurship. Here are five of our top takeaways:It’s a tough transition“To be frank, it was nerve-wracking at times.

  • 1 week ago | imperial.ac.uk | David Silverman

    Imperial College London is working with Apollo Therapeutics to develop a prospective monoclonal antibody treatment for pulmonary arterial hypertension (PAH), a rare life-limiting condition for which there is no cure. The potential treatment is based on a protein that was identified in original research by the university, and is currently undergoing a proof of concept trial at Hammersmith Hospital, part of Imperial College Healthcare NHS Trust.

  • 1 week ago | imperial.ac.uk | David Silverman

    Solena Materials has raised $6.7 million (£5.1 million) in seed funding, following a $4.1 million (£3.1 million) pre-seed funding round in 2022, that it will use to produce protein fibres at scale. The company uses AI techniques to custom-design fibres at the molecular level which are then produced using engineered microbes.

  • 2 weeks ago | imperial.ac.uk | Ian Mundell

    Joint replacement patients could stay active for longer thanks to a 3D-printed material from Imperial startup OSSTEC, which has raised a further £2.5 million to take its technology to the market. Based on novel material that behaves like bone, the company’s joint replacement system promises to simplify surgery, reduce implant failures and keep patients active for longer. The funding means that the technology is now closer to entering clinical use.